Annual SG&A
$80.39 M
+$13.80 M+20.72%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual selling, general & administrative expenses is currently $80.39 million, with the most recent change of +$13.80 million (+20.72%) on 31 December 2023. During the last 3 years, it has risen by +$15.24 million (+23.38%). AMPH annual SG&A is now at all-time high.AMPH Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$23.82 M
+$1.52 M+6.81%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly selling, general & administrative expenses is currently $23.82 million, with the most recent change of +$1.52 million (+6.81%) on 30 September 2024. Over the past year, it has increased by +$4.75 million (+24.95%). AMPH quarterly SG&A is now -4.91% below its all-time high of $25.05 million, reached on 31 March 2024.AMPH Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$1.88 B
+$157.72 M+9.14%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM selling, general & administrative expenses is currently $1.88 billion, with the most recent change of +$157.72 million (+9.14%) on 30 September 2024. Over the past year, it has increased by +$1.81 billion (+2418.90%). AMPH TTM SG&A is now at all-time high.AMPH TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | +24.9% | +2418.9% |
| 3 y3 years | +23.4% | +52.1% | +2588.2% |
| 5 y5 years | +38.5% | +67.2% | +2773.0% |
AMPH Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.4% | -4.9% | +62.1% | at high | +254.1% |
| 5 y | 5 years | at high | +38.5% | -4.9% | +70.3% | at high | +409.9% |
| alltime | all time | at high | +163.3% | -4.9% | +208.7% | at high | +2451.1% |
Amphastar Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.82 M(+6.8%) | $92.90 M(+5.4%) |
| June 2024 | - | $22.30 M(-11.0%) | $88.15 M(+3.9%) |
| Mar 2024 | - | $25.05 M(+15.2%) | $84.85 M(+5.5%) |
| Dec 2023 | $80.39 M(+20.7%) | $21.74 M(+14.1%) | $80.39 M(+7.5%) |
| Sept 2023 | - | $19.06 M(+0.3%) | $74.75 M(+3.2%) |
| June 2023 | - | $19.00 M(-7.7%) | $72.46 M(+4.7%) |
| Mar 2023 | - | $20.59 M(+27.9%) | $69.19 M(+3.9%) |
| Dec 2022 | $66.59 M(-3.4%) | $16.10 M(-4.0%) | $66.59 M(+2.2%) |
| Sept 2022 | - | $16.77 M(+6.6%) | $65.19 M(+1.7%) |
| June 2022 | - | $15.73 M(-12.5%) | $64.08 M(-4.4%) |
| Mar 2022 | - | $17.99 M(+22.4%) | $67.03 M(-2.7%) |
| Dec 2021 | $68.92 M(+5.8%) | $14.70 M(-6.1%) | $68.92 M(-1.6%) |
| Sept 2021 | - | $15.65 M(-16.3%) | $70.04 M(+0.4%) |
| June 2021 | - | $18.69 M(-5.9%) | $69.74 M(-1.8%) |
| Mar 2021 | - | $19.88 M(+25.6%) | $70.99 M(+9.0%) |
| Dec 2020 | $65.16 M(+3.2%) | $15.82 M(+3.1%) | $65.16 M(+2.9%) |
| Sept 2020 | - | $15.35 M(-23.1%) | $63.32 M(+1.8%) |
| June 2020 | - | $19.95 M(+42.1%) | $62.21 M(+7.9%) |
| Mar 2020 | - | $14.04 M(+0.4%) | $57.68 M(-8.6%) |
| Dec 2019 | $63.11 M(+8.7%) | $13.98 M(-1.8%) | $63.11 M(-3.7%) |
| Sept 2019 | - | $14.24 M(-7.6%) | $65.54 M(-1.7%) |
| June 2019 | - | $15.42 M(-20.8%) | $66.67 M(+2.9%) |
| Mar 2019 | - | $19.47 M(+18.6%) | $64.79 M(+11.6%) |
| Dec 2018 | $58.04 M | $16.41 M(+6.8%) | $58.04 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $15.37 M(+13.5%) | $52.48 M(+3.9%) |
| June 2018 | - | $13.54 M(+6.5%) | $50.53 M(-0.6%) |
| Mar 2018 | - | $12.72 M(+17.2%) | $50.82 M(-0.2%) |
| Dec 2017 | $50.92 M(+7.7%) | $10.85 M(-19.2%) | $50.92 M(-2.6%) |
| Sept 2017 | - | $13.42 M(-3.0%) | $52.26 M(+2.6%) |
| June 2017 | - | $13.83 M(+7.9%) | $50.93 M(+6.3%) |
| Mar 2017 | - | $12.82 M(+5.1%) | $47.89 M(+1.3%) |
| Dec 2016 | $47.30 M(+0.7%) | $12.19 M(+0.8%) | $47.30 M(+4.8%) |
| Sept 2016 | - | $12.09 M(+12.1%) | $45.12 M(+4.4%) |
| June 2016 | - | $10.79 M(-11.7%) | $43.23 M(-4.4%) |
| Mar 2016 | - | $12.22 M(+22.0%) | $45.22 M(-3.7%) |
| Dec 2015 | $46.97 M(+16.4%) | $10.02 M(-1.8%) | $46.97 M(-2.6%) |
| Sept 2015 | - | $10.21 M(-20.1%) | $48.22 M(-1.6%) |
| June 2015 | - | $12.78 M(-8.6%) | $49.03 M(+6.0%) |
| Mar 2015 | - | $13.97 M(+24.0%) | $46.24 M(+14.5%) |
| Dec 2014 | $40.37 M(+11.2%) | $11.27 M(+2.3%) | $40.37 M(+5.1%) |
| Sept 2014 | - | $11.01 M(+10.2%) | $38.40 M(+0.0%) |
| June 2014 | - | $9.99 M(+23.3%) | $38.40 M(+6.3%) |
| Mar 2014 | - | $8.10 M(-12.8%) | $36.12 M(-0.5%) |
| Dec 2013 | $36.32 M(+14.8%) | $9.30 M(-15.5%) | $36.32 M(+34.4%) |
| Sept 2013 | - | $11.01 M(+42.7%) | $27.02 M(+68.7%) |
| June 2013 | - | $7.72 M(-7.0%) | $16.02 M(+93.0%) |
| Mar 2013 | - | $8.30 M | $8.30 M |
| Dec 2012 | $31.65 M(+3.7%) | - | - |
| Dec 2011 | $30.53 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual SG&A year-on-year change?
- What is Amphastar Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly SG&A year-on-year change?
- What is Amphastar Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM SG&A year-on-year change?
What is Amphastar Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of AMPH is $80.39 M
What is the all time high annual SG&A for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual selling, general & administrative expenses is $80.39 M
What is Amphastar Pharmaceuticals annual SG&A year-on-year change?
Over the past year, AMPH annual selling, general & administrative expenses has changed by +$13.80 M (+20.72%)
What is Amphastar Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of AMPH is $23.82 M
What is the all time high quarterly SG&A for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $25.05 M
What is Amphastar Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, AMPH quarterly selling, general & administrative expenses has changed by +$4.75 M (+24.95%)
What is Amphastar Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of AMPH is $1.88 B
What is the all time high TTM SG&A for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM selling, general & administrative expenses is $92.90 M
What is Amphastar Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, AMPH TTM selling, general & administrative expenses has changed by +$1.81 B (+2418.90%)